Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes


International Standard Randomised Controlled Trial Number Register
Showing records: 5591 to 5600 of 9074
SEARCH FOR RESULTS ORDER DIRECTION MAX RESULTS
5591 A phase III, multinational, randomised, double-blind, placebo-controlled, parallel-group study to investigate the clinical efficacy and safety of Diapep277™ in newly diagnosed type one diabetes patients
ISRCTN: ISRCTN55429664
Sponsor: Andromeda Biotech Ltd (Israel)
Date assigned: 21 October 2005
5592 Randomised, double-blind, placebo-controlled, multi-centre, parallel group study to investigate the safety and tolerability as well as the immunological and clinical effects of multiple subcutaneous doses of DiaPep277 in latent autoimmune diabetes in adults (LADA) patients
ISRCTN: ISRCTN50665418
Sponsor: DeveloGen AutoImmune GmbH (Germany)
Date assigned: 21 October 2005
5593 Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: a double-blinded, randomised clinical trial
ISRCTN: ISRCTN71482124
Sponsor: Physicians' Services Incorporated Foundation (Canada)
Date assigned: 21 October 2005
5594 Motivational interviewing: altering outcome after stroke
ISRCTN: ISRCTN54465472
Sponsor: Royal Liverpool University Hospital (UK)
Date assigned: 21 October 2005
5595 Efficacy of zinc as an adjunct therapy in the management of severe pneumonia among Gambian children
ISRCTN: ISRCTN33548493
Sponsor: Medical Research Council (UK)
Date assigned: 21 October 2005
5596 Evaluation of gabapentin as a preemptive analgesic for patients undergoing total hip arthroplasty
ISRCTN: ISRCTN14907042
Sponsor: Sunnybrook Health Sciences Centre (Canada)
Date assigned: 20 October 2005
5597 Development, implementation and evaluation of an integrated follow-up programme for people with cutaneous malignant melanoma
ISRCTN: ISRCTN71577271
Sponsor: University of Aberdeen (UK)
Date assigned: 19 October 2005
5598 The effects of botulinum toxin A on patients with idiopathic detrusor overactivity. A double-blind, randomised, placebo-controlled trial.
ISRCTN: ISRCTN16995641
Sponsor: Guy's and St Thomas' NHS Foundation Trust (UK)
Date assigned: 19 October 2005
5599 Subclinical hypothyroidism (SCH), cardiovascular risk and quality of life
ISRCTN: ISRCTN35570362
Sponsor: Gateshead Health NHS Foundation Trust (UK)
Date assigned: 19 October 2005
5600 Autologous Stem cell Transplantation International Scleroderma (ASTIS) Trial
ISRCTN: ISRCTN54371254
Sponsor: European Group Bone Marrow + Transplantation (EBMT)/European League Against Rheumatism (EULAR) Working Party Autoimmune Diseases
Date assigned: 19 October 2005
RESULT PAGE
|< < 556 557 558 559 560 561 562 563 564 > >|
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central